Literature DB >> 6236921

Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.

H N Willcox, J Newsom-Davis, L R Calder.   

Abstract

In most young myasthenia gravis patients, the thymic medulla contains germinal centres. Thymocytes from these cases spontaneously synthesize anti-acetylcholine receptor autoantibody (anti-AChR) in culture; after irradiation they may also selectively stimulate anti-AChR antibody production by autologous blood lymphocytes. By depleting cortical or mature thymic T cells by complement killing, we now show that neither of these responses depends on thymic T cells, unlike the total IgG response to pokeweed mitogen which is T cell-dependent and shows T/B cell synergy. The results suggest that much of the spontaneous anti-AChR production is by autonomous thymic plasma cells, which may be HLA-DR-. The ability to stimulate autologous blood lymphocytes does not require viable HLA-DR+ thymic cells but appears to depend on rare antigen presenting cells from the germinal centres. In preliminary experiments, blood T cells were apparently also necessary.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6236921      PMCID: PMC1576978     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

Review 1.  A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator.

Authors:  A G Bird; S Britton
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  The generation of memory cells. I. The role of C3 in the generation of B memory cells.

Authors:  G G Klaus; J H Humphrey
Journal:  Immunology       Date:  1977-07       Impact factor: 7.397

3.  Analysis of HLA-D region-associated molecules with monoclonal antibody.

Authors:  D J Charron; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

4.  Reaginic antibody formation in the mouse. XI. Participation of long-lived antibody-forming cells in persistent antibody formation.

Authors:  H Okudaira; K Ishizaka
Journal:  Cell Immunol       Date:  1981-02       Impact factor: 4.868

5.  Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes.

Authors:  H N Willcox; J Newsom-Davis; L R Calder
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

6.  Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology.

Authors:  G K Scadding; A Vincent; J Newsom-Davis; K Henry
Journal:  Neurology       Date:  1981-08       Impact factor: 9.910

7.  Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes.

Authors:  A G Engel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

Review 8.  Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.

Authors:  K E Osserman; G Genkins
Journal:  Mt Sinai J Med       Date:  1971 Nov-Dec

9.  A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody.

Authors:  A J McMichael; J R Pilch; G Galfré; D Y Mason; J W Fabre; C Milstein
Journal:  Eur J Immunol       Date:  1979-03       Impact factor: 5.532

10.  Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.

Authors:  J Newsom-Davis; N Willcox; L Calder
Journal:  N Engl J Med       Date:  1981-11-26       Impact factor: 91.245

View more
  15 in total

1.  Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy.

Authors:  J B Kuks; P C Limburg; H J Oosterhuis; T H The
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

2.  Synthesis of anti-acetylcholine receptor antibodies by CD5- B cells from peripheral blood of myasthenia gravis patients.

Authors:  F Heidenreich; T Jovin
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

3.  Phenotypic characteristics of thymic B lymphocytes in myasthenia gravis.

Authors:  B Zweiman; A I Levinson; R P Lisak
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

Review 4.  B cells in the pathophysiology of myasthenia gravis.

Authors:  John S Yi; Jeffrey T Guptill; Panos Stathopoulos; Richard J Nowak; Kevin C O'Connor
Journal:  Muscle Nerve       Date:  2017-09-30       Impact factor: 3.217

5.  Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis.

Authors:  Panos Stathopoulos; Aditya Kumar; Richard J Nowak; Kevin C O'Connor
Journal:  JCI Insight       Date:  2017-09-07

6.  Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis.

Authors:  Ruoyi Jiang; Kenneth B Hoehn; Casey S Lee; Minh C Pham; Robert J Homer; Frank C Detterbeck; Inmaculada Aban; Leslie Jacobson; Angela Vincent; Richard J Nowak; Henry J Kaminski; Steven H Kleinstein; Kevin C O'Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-16       Impact factor: 11.205

7.  In vitro anti-acetylcholine receptor antibody synthesis by myasthenia gravis patient lymphocytes: correlations with thymic histology and thymic epithelial-cell interactions.

Authors:  D Safar; S Berrih-Aknin; E Morel
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

8.  Anti-acetylcholine receptor antibodies induced in mice by syngeneic receptor without adjuvants.

Authors:  G K Scadding; L Calder; A Vincent; C Prior; D Wray; J Newsom-Davis
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

9.  The stromal cell antigen CD248 (endosialin) is expressed on naive CD8+ human T cells and regulates proliferation.

Authors:  Debbie L Hardie; Mathew J Baldwin; Amy Naylor; Oliver J Haworth; Tie Zheng Hou; Sian Lax; S John Curnow; Nick Willcox; John MacFadyen; Clare M Isacke; Christopher D Buckley
Journal:  Immunology       Date:  2011-04-06       Impact factor: 7.397

10.  Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients.

Authors:  Nick Willcox; Pilar Martinez-Martinez; Mario Losen; Alejandro M Gomez; Kathleen Vrolix; Jonas Hummel; Gisela Nogales-Gadea; Abhishek Saxena; Hans Duimel; Fons Verheyen; Peter C Molenaar; Wim A Buurman; Marc H De Baets
Journal:  J Immunol       Date:  2014-06-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.